Clinical Trial Update: A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating remimazolam for intraoperative sedation in pediatric and adolescent patients has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Operative Sedation of Adolescent Patients
• Operative Sedation of Pediatric Patients

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Operative Sedation of Pediatric, Operative Sedation of Adolescent Patients | Phase 2, Phase 3 | Status: COMPLETED